Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04112914 · ClinicalTrials.gov registry record · NA

Developing an Implementation Strategy for Post-concussion Communication With Low Health Literacy Parents in the Emergency Department

A NA study of Concussion, Brain, sponsored by Seattle Children's Hospital.

Completed
Registry status
NA
Development phase
98
Enrollment target
1
Study location

NCT04112914: Completed NA study of Concussion, Brain, sponsored by Seattle Children's Hospital.

NCT04112914 is a NA study of Concussion, Brain that has completed, run by Seattle Children's Hospital. The registered enrollment target is 98 participants, below the 180-participant average among 20 other Concussion, Brain trials with a reported enrollment target (46% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04112914, a NA study of Concussion, Brain, has completed, sponsored by Seattle Children's Hospital.

COMPLETED
Registry status
NA
Development phase
98 participants
Enrollment target
1
Study location

Study Summary

Investigators will conduct a hybrid implementation-effectiveness evaluation of an educational intervention that supports communication with families post-concussion in the emergency department. Primary outcomes will be parent self-report of specific concussion management behaviors two weeks post-visit. Investigators will also explore whether successful implementation is associated with (1) improved parent knowledge and self-efficacy related to helping their child adhere to CDC guidelines for returning to daily activities, school and sports, and (2) decreased disparity in knowledge and self-efficacy between high and low health literacy parents.

Primary Outcome

Parent self-report of specific emotionally supportive concussion management behaviors in the home setting using the emotionally supportive behaviors index. This index is comprised of three communication practices: whether they had talked to their child about "how they are feeling emotionally (e.g., sadness, anxiety)", "the time it takes to recover from a head injury can be different from person to person," and "their concerns about their recovery from head injury." Responses were summed to creat

Conditions Studied

Interventions

  • BEHAVIORAL Post-concussion education for families

Study Locations (1)

Washington

  • Seattle Children's Hospital Emergency Department - Seattle

Trial Details

FieldValue
Enrollment Target 98 participants
Start Date 2021-01-05
Est. Completion 2022-07-27
Phase NA
Seattle Children's Hospital

168 total trials

What the finished NCT04112914 record still lists

NCT04112914 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 98 participants, a relatively small participant target, below the 180-participant average among 20 other Concussion, Brain trials with a reported enrollment target (46% lower).

The record links to 1 condition, with Concussion, Brain appearing as the primary indexed condition, and to 1 intervention - of which Post-concussion education for families is the first listed.

NCT04112914 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT04112914 about?

NCT04112914 is a clinical study titled "Developing an Implementation Strategy for Post-concussion Communication With Low Health Literacy Parents in the Emergency Department". Investigators will conduct a hybrid implementation-effectiveness evaluation of an educational intervention that supports communication with families post-concussion in the emergency department. Primary outcomes will be parent self-report of specific concussion management behaviors two weeks post-vis...

What is the current status of trial NCT04112914?

This trial is currently completed. It is a NA study. The enrollment target is 98 participants. The study started on 2021-01-05. Estimated completion is 2022-07-27.

What conditions does trial NCT04112914 study?

This clinical trial studies the following conditions: Concussion, Brain.

What interventions are being tested in trial NCT04112914?

The interventions under investigation include: Post-concussion education for families (BEHAVIORAL).

Who is sponsoring clinical trial NCT04112914?

This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04112914 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Concussion, Brain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04112914's enrollment target sits among peer trials

98 11th of 20 higher than 10 of 20 other Concussion, Brain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Concussion, Brain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02926729 · 98 participants · NA

    Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy

  • NCT03382977 · 98 participants · Phase 1

    Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects

  • NCT04577014 · 98 participants · Phase 1

    Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma

  • NCT04817618 · 98 participants · Phase 3

    Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04112914, the US trial registry maintained by the National Library of Medicine. NCT04112914 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.